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Carbamazepine (CBZ) is being prescribed more frequently 
for treatment of children and adults with generalized tonic- 
clonic and partial complex seizures. Early reports of aplastic 
anemia in elderly patients treated with this drug led to con- 
cern about its potential hematological toxicity. A variety of 
other hematological abnormalities have also been described 
in association with CBZ therapy, including agranulocytosis, 
thrombocytopenia, and transient leukopenia. The drug label- 
ing recommends frequent blood tests and includes strict 
guidelines for discontinuation of therapy if relatively minor 
abnormalities occur, for example, total white blood cell count 
(WBC) less than 4,000 per cubic millimeter. Several authors 
have questioned the validity and practicality of these guide- 
lines El]. In fact, routine monitoring is not practiced at cer- 
tain epilepsy centers. The major objection raised is that 
routine monitoring does not help predict which patients will 
develop severe idiosyncratic drug reactions. 
It has been suggested that children are less likely than 
adults to develop hematological abnormalities while receiving 
CBZ therapy, but few large pediatric series have been re- 
ported. T o  determine the incidence and severity of 
hematological problems associated with CBZ, we reviewed 
the records of 200 children who attended the Pediatric 
Neurology Clinic at the University of Michigan Medical Cen- 
ter from 1978 to 1982 [4}. We compared two groups of 
patients. Group 1 consisted of 125 children in whom therapy 
was initiated before age 12 (39 were less than 6 years old); 
group 2 included 75 children who were between 12 and 17 
years old at the start of therapy. Mean duration of treatment 
(18 months), mean CBZ level (6 CLgiml), and mean number 
of other anticonvulsants (1.5) were the same for the two 
groups. N o  patient developed any symptomatic hematolog- 
ical problem. 
The Table summarizes the results of hematological sur- 
veillance in these children. Leukopenia (WBC less than 4,000 
per cubic millimeter) was the most frequently noted abnor- 
mality and was almost twice as common in the younger age 
group. In most patients leukopenia resolved while CBZ 
therapy was continued, but 4 of the 200 had persistent or 
recurrent leukopenia while taking the drug. The drug was 
discontinued in 3 patients because of leukopenia. There was 
no detectable clinical difference between the patients in 
whom the drug was stopped and those for whom the decision 
was made to continue treatment. 
Based on our experience and published series [3], it ap- 
pears that CBZ is a relatively safe drug for children with 
seizures. However, although it is possible that leukopenia 
was sometimes unrelated to CBZ, its occurrence in a minor- 
ity of patients merits further investigation and suggests that 
hematological surveillance is appropriate. Although reports 
in the literature are inconsistent about the value of routine 
blood counts in preventing or altering the outcome of 
Hematological Abnormalities in  Children 
Treated with Carbamazepine for Seizures 
Abnormality (n = 125)" in = 75)b 
No. in Group 1 No. in Group 2 
Hgb < 12 gm 0 0 
WBC < 4,000/mmi 21 ( 1 7 p )  6 (8r%) 
WBC < 4,000/mm3 4 0 
Platelets < 200,000 2 2 
3 mo or longer 
"Age range, 1 to 11 years. 
hAge range, 12 to 17 years. 
Hgb = hemoglobin; WBC = white blood cell count 
idiosyncratic drug-related aplastic anemia, reputable au- 
thorities do recommend monitoring, especially for newer 
drugs [2}. The justifications for monitoring with CBZ 
therapy include early identification of patients developing po- 
tentially reversibie symptomatic neutropenia or agranulocy- 
tosis, accumulation of more information about the natural 
history of drug-related leukopenia, and, possibly, early 
identification of patients developing aplastic anemia. 
The available data are insufficient to indicate the mecha- 
nism of neutropenia [ 5 }  or to support a particular schedule of 
laboratory testing. We suggest the following guidelines as a 
practical minimum: 
Hemoglobin, hematocrit, WBC, and platelet estimate be- 
fore therapy, monthly for six months, and then every 
three months. 
If total WBC falls to less than 4,000 per cubic millimeter, 
neutrophil, platelet, and reticulocyte counts. 
If neutrophil count falls to 1,000 to 1,500 per cubic mil- 
limeter and the patient is well, repeat in  two weeks; if still 
in this range, consider discontinuing therapy unless 
strongly indicated. If neutrophil count drops below 1,000 
per cubic millimeter, decrease dosage or discontinue drug 
and repeat count in two weeks. 
If, in addition to neutropenia, there is a depression in 
platelet o r  reticulocyte count, hematological consultation 
is advisable. 
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Familial Periodic Paralysis: 
Low Muscle Potassium 
Permeability or High 
Sodium Permeability? 
J. J. Schipperheyn, MD, PhD,* 
and 0. J. S. Buruma, MD, PhDi- 
The recent article in the Annals on periodic paralysis and the 
sodium potassium pump by Robert B. Layzer [ 5 ]  ends with a 
provocative attempt to postulate a single membrane abnor- 
mality that accounts for the attacks of inexcitability of skeletal 
muscle in familial periodic paralysis. I t  would be satisfying 
indeed to demonstrate that a single pinpoint lesion of t h e  
membrane could lead to such an impressive symptom. 
Layzer’s hypothesis is based on the assumption that attacks 
are induced by the low extracellular potassium ([K]J concen- 
tration that is either caused locally in affected muscles or 
generalized in the whole body by overactivity of the Na-K 
pump during periods of rest. Inexcitability results, according 
to this hypothesis, from depolarization of the membrane 
caused by a decrease in permeability to potassium (PK). The 
PK is lowered, supposedly, by the effect of the low [K],, on 
the potassium permeability of the membrane. By itself the 
decrease in PK can increase the membrane potentials to 
values above -50 mV, enough to inactivate fast sodium 
transport. Layzer supposes that, as in cases of barium poison- 
ing, membrane voltage can be temporarily maintained close 
to its normal level by the electrogenic part of the Na-K 
pump, its effect enhanced by the increased membrane resis- 
tance. 
Apart from the fact that the hypothesis fails to explain why 
paresis develops before [K], is lowered, it is not in keeping 
with pertinent observations made by a number of inves- 
tigators. Most direct measurements of membrane voltage 
have revealed that during attacks the membrane is inexcitable 
but nevertheless not or only slightly depolarized 14, 6, 7, 81, 
and rarely depolarized far enough to fully inactivate fast 
sodium transport. Moreover, direct measurements of total 
membrane resistance are consistent with an increase in PK 
rather than with a reduction. From the simplified Hodgkin 
and Katz equations 131 valid for steady-state conditions, it can 
be calculated that for PNa/PK ratios above 0.05, membrane 
potential is practically constant for all practical values of IK], 
below 4.5 mmoVL. All this evidence supports the hypothesis 
that during attacks PNa increases and not that PK decreases. In 
this respect it is interesting that procaine, which selectively 
blocks sodium transport, partly restores excitability [4] .  
The assumption that P N ~  is raised is in agreement with 
observations pointing to a cell-inward transport of water and 
Na and CI ions early during attacks. The presence of Na ions 
at the inner surface of the membrane always strongly stimu- 
lates active Na-K transport, which can lower serum potas- 
sium levels rapidly. As Layzer states [ 5 ] ,  it would not be 
difficult to construct another hypothetical scheme based on 
high PNa A high PNa seems more in keeping with the experi- 
mental data than does a low PK. A high PNd, however, does 
not automatically explain the inactivation of fast Na trans- 
port. 
Therefore, the scheme needs to be expanded. Poisoning of 
the muscle membrane by a venom extracted from the scor- 
pion centruroides sculpturatus provides an interesting model 
for familial periodic paralysis. This venom not only blocks 
fast N a  transport, as does tetrodotoxin, but simultaneously 
increases resting PNa [I]. The resulting changes in membrane 
properties closely parallel the observed changes during at- 
tacks of periodic paralysis. Scorpion venom is a polypeptide, 
and one can easily complete the high P N ~  scheme by postulat- 
ing an inborn error of cellular protein metabolism that occa- 
sionally leads to the synthesis of a toxic polypeptide. The 
sensitivity for rest after strenuous exercise, and for glucose 
and insulin, points in the same direction. It also fits in with 
the fact that continuously active muscles (such as those used 
in respiration) are usually not affected, and that acidosis, 
which inhibits protein synthesis, prevents attacks. 
The assumption that protein synthesis is deranged may 
seem a bit farfetched, but ultrastructural analysis has revealed 
that the metabolic apparatus of the skeletal muscle cell is 
probably abnormal C21. The idea that the attacks are caused 
by some form of autointoxication was formulated as early as 
1891, but it remains difficult, and perhaps impossible, to 
prove such a postulated mechanism. Nevertheless, we be- 
lieve that a high PNa scheme fits the data far more closely than 
does the low PK hypothesis. 
‘Department of Cardiology, Division of Experimental Cardiology, 
UniverJity Hospital Leiden 
Leiden. Netherlands 
and ?Department of Neurology 
References 
1. Cahalan MI): Modification of sodium channel gating in frog my- 
elinated nerve fibres by centruroides sculpturatus scorpion 
venom. J Physiol (Lond) 244:511-534, 1975 
2. Engel AG: Evaluation and content of vacuoles in primary hy- 
pokalaemic periodic paralysis. Proc Mayo Clin 45:774-8 14, 1970 
3. Hodgkin AL, Katz B: The effect of sodium ions on the electrical 
activity of the giant axon of the squid. J Physiol (Lond) 108:37- 
7 7 ,  1949 
4. Hofmann W, Smith RA: Hypokalaemic periodic paralysis studied 
in vitro. Brain 93:445-474, 1970 
5 .  Layzer RB: Periodic paralysis and the sodium potassium pump. 
Ann Neurol 11:547-552, 1982 
6. McComas AJ, Mrozek K, Bradley WG: The nature of electro- 
physiologic disorder in adynamia episodica. J Neurol Neurosurg 
Psychiatry 31:448-452, 1967 
7. Norris FH: Micropipette recording from human striated muscle. J 
Neurol 213:l-15, 1976 
8. Riecker G, Bolte HD: Mebranpotentiale einzelner Skeletmuskel 
Zellen bei hypokalimischer periodischer Muskelparalyse. U n  
Wochenschr 44:804-807, 1966 
686 Annals of Neurology Vol 13 No 6 June 1983 
